Prostaglandin (PG) E2 is an important inflammatory mediator. We examined pH value and PGE2 concentration in exhaled breath condensate (EBC) in 22 stable CF adults (11 M) aged 25.6±4.1 years (mean ± SD) with FEV1 60.7±21.6% pred. and in 12 (4 M) healthy controls aged 27.6±4.2 years by using ECoScreen condenser. pH was measured without deaeration immediately after collection (Titan pH-meter with CupFET probe). Samples for PGE2 evaluation were stored frozen at -80ºC untill they were examined with Luminex technology (lower detection limit 35 pg/ml). PGE2 was detectable in all CF patients and healthy controls. EBC pH was lower in stable CF than in healthy controls (5.50±0.57 vs. 6.09±0.37; p = 0.0013) whereas EBC PGE2 was higher (6816±4119 vs. 4228±1613 pg/ml; p = 0.027). In stable CF patients, EBC concentration of PGE2 tended to negative correlation with EBC pH (r = −0.344; p = 0.122) and was negatively correlated to FEV1 (r = -0.492; p = 0.02) in contrast to EBC pH, where positive correlation with FEV1 (r = 0.444; p = 0.038) was found. We conclude that EBC PGE2 concentration is higher in stable CF patients than in healthy controls and is negatively correlated to pulmonary function. Supported by: IGA MZCR NR/8304−3. Pseudomonas aeruginosa is known to be the main pathogen that infects lungs of cystic fibrosis patients. The innate defense against this pathogen, and many others, is mediated in part through the recognition of specific microbial ligands by Toll-like receptors (TLR), of which there are at least 10 in humans. From in vivo experiments, using TLR knockout mice, it is assumed that the control of P. aeruginosa occurs through the recognition of LPS and flagellin by TLR2,4 and 5 respectively. In the present study, we investigated in vitro the role of these same TLR and ligands, in relation to alveolar macrophages (AM) and respiratory epithelial cells (EC) activation. Cellular responses to P. aeruginosa were evaluated in terms of KC, TNF-a, IL-6 and G-CSF secretion, four markers of the innate immune response. AM and EC from WT and knockout mice for TLR2,4 and TLR4,5 were stimulated with the wild-type P. aeruginosa or with a mutant devoid of flagellin expression. cPLA2 belonging to a superfamily of enzymes, selectively release arachidonic acid (AA) from membrane PL. AA metabolites play a role in inflammation. P. aeruginosa is an opportunistic G − bacteria that infects immuno-compromised and cystic fibroblast patients. This results in high mortality due to its notorious resistance to antibiotics. We postulated that cPLA2 may play a key role in P. aeruginosa induced lung inflammation. Our results showed that in A549 epithelial cells, a WT-strain of P. aeruginosa (PAK) increased cPLA2 phosphorylation which reflects its activation, suggesting that cPLA2 may be involved in P. aeruginosa-induced inflammation. Both PAK and another P. aeruginosa strain, PAO1, induced a time-dependent AA release from A549 cells. The production of prostaglandin E2 (PGE2), a metabolite of AA, was increased markedly by PAK which also induced IL8 synthesis. Meanwhile, PAK induced p38MAPK phosphorylation in a time-and dose-dependent manner. SB2035803, a specific inhibitor of p38MAPK, abolished the effect of PAK on both PGE2 and IL8 synthesis. The expression of cyclooxygenase (COX), which converts AA into PGE2, was increased after PAK stimulation. Finally, the effects of different virulence factors isolated from P. aeruginosa were investigated. LPS had no effect on PGE2 release and IL8 synthesis. Flagellin increased IL8 expression but had no effect on PGE2 release. The Dflic strain, in which the flagellin gene was deleted, had less effect on IL8 synthesis but had similar effect on PGE2, as compared to the PAK strain. Collectively, our results show that cPLA2 is involved in P. aeruginosa-induced inflammation through a process of p38MAPK. However, the virulence factors involved in cPLA2 activation remains to be identified.
209* Comparison of Inflammatory responses to

